iBio, Inc. (IBIO):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:iBio, Inc. (IBIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH140013FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

iBio, Inc. (iBio) is a biotechnology company. The company develops and offers pharmaceutical product applications. It offers products such as vaccines, and biotherapeutics. iBio offers vaccines such as influenza vaccines, malaria, hookworm, yellow fever, human papilloma virus, and bacterial pathogens. The company’s biotherapeutics sectors include human growth factors, proteins derived from human blood, monoclonal antibodies, and replacement enzymes. It offers collaborations with biotechnology and pharmaceutical companies throughout-licensing its pipeline of products produced with the ibiolaunch platform; partnering its technology for exploratory, research or validation studies; and out-licensing the ibiolaunch platform for the production of biotherapeutics and vaccines. The company markets its products through brand: iBioLaunch. iBio is headquartered in Newark, Delaware, the US.

iBio, Inc. Key Recent Developments

Nov 05, 2013: iBio Appoints Senior Management for New Business Unit, iBio Brazil
Oct 28, 2013: iBio Resolves NYSE MKT Listing Standards Deficiency
Oct 14, 2013: iBio Receives Notice that NYSE MKT Grants Extension to Regain Compliance with Continued Listing Standards and Corrects Misleading Third-Party Statements
Sep 05, 2013: iBio to Present at the 2013 Gateway Conference on September 10
Aug 13, 2013: iBio IP Expanded by New iBioLaunch Dual Vector Patent Allowance

This comprehensive SWOT profile of iBio, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of iBio, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

iBio, Inc. – Key Information
iBio, Inc. – Overview
iBio, Inc. – Key Employees
iBio, Inc. – Key Employee Biographies
iBio, Inc. – Key Operational Heads
iBio, Inc. – Major Products and Services
iBio, Inc. – History
iBio, Inc. – Company Statement
iBio, Inc. – Locations And Subsidiaries
iBio, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

iBio, Inc. – Business Description
iBio, Inc. – Corporate Strategy
iBio, Inc. – SWOT Analysis
SWOT Analysis – Overview
iBio, Inc. – Strengths
iBio, Inc. – Weaknesses
iBio, Inc. – Opportunities
iBio, Inc. – Threats
iBio, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

iBio, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

iBio, Inc., Key Information
iBio, Inc., Key Ratios
iBio, Inc., Share Data
iBio, Inc., Major Products and Services
iBio, Inc., History
iBio, Inc., Key Employees
iBio, Inc., Key Employee Biographies
iBio, Inc., Key Operational Heads
iBio, Inc., Other Locations
iBio, Inc., Subsidiaries
iBio, Inc., Key Manufacturing facilities
iBio, Inc., Key Competitors
iBio, Inc., SWOT Analysis
iBio, Inc., Ratios based on current share price
iBio, Inc., Annual Ratios
iBio, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

iBio, Inc., Performance Chart
iBio, Inc., Ratio Charts

★海外企業調査レポート[iBio, Inc. (IBIO):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New England Biolabs Inc-製薬・医療分野:企業M&A・提携分析
    Summary New England Biolabs Inc (NEB) is a life science company that develops recombinant and native enzymes for genomic research. The company offers products such as competent cells, DNA plasmids, protein tools, buffers and strains, and others. It has applications in cloning and synthetic biology, …
  • Labcyte, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Labcyte, Inc. Mergers and Acqui …
  • Sanochemia Pharmazeutika AG (SAC)-医療機器分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • Cablevision Systems Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Cablevision Systems Corporation …
  • RMP Energy Inc. (RMP):企業のM&A・提携動向(石油・ガス分野)
    Summary RMP Energy Inc. (RMP) is an upstream oil and gas producer that explores, develops and produces natural gas, crude oil and natural gas liquid in Canada. The company operates its core operations in the Montney light oil fairway at Ante Creek, Waskahigan and Grizzly in West Central Alberta. Its …
  • Halliwells LLP:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Halliwells LLP Mergers and Acqu …
  • Kirin Holdings Co Ltd:戦略・SWOT・企業財務分析
    Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Kirin Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • University of Mississippi:企業のM&A・提携動向(医療分野)
    Summary University of Mississippi (UOM) is an educational service provider that provides various education and research programs. The university offers undergraduate and graduate courses and research programs. It provides programs in the fields of applied science, business administration, engineerin …
  • BioPorto Diagnostics AS (BIOPOR):企業のM&A・提携動向(医療機器分野)
    Summary BioPorto Diagnostics A/S (BioPorto Diagnostics) is an in-vitro diagnostics company. The company develops and markets antibodies and antibody based products. BioPorto Diagnostics product categories include antibodies, matched antibody pairs, matched reagent set, immunoassays, antigens, contro …
  • Cabot Oil & Gas Corporation (COG):企業のM&A・提携動向(石油・ガス分野)
    Summary Cabot Oil & Gas Corporation (Cabot) is an independent oil and gas company, which develops, exploits, and explores oil and gas properties primarily in the continental US. It focuses on developing natural gas resources in the Marcellus shale in northeast Pennsylvania and oil development in the …
  • Assembly Biosciences, Inc. (ASMB):企業概要、財務及び戦略的SWOT分析
    Summary Assembly Biosciences, Inc. (Assembly) is a pharmaceutical company. The company develops and commercializes pharmaceutical drug products used in the treatment of gastrointestinal disorders such as anal fissures, and fecal incontinence. Its products under clinical development include VEN 307, …
  • Santander Private Bank:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Santander Private Bank" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fo …
  • Crew Energy Inc. (CR):企業のM&A・提携動向(石油・ガス分野)
    Summary Crew Energy Inc. (Crew Energy) is an oil and gas company which focuses on the exploration and production of oil and natural gas resources. Its portfolio of services includes strategic acquisitions, exploration, development and production. The company primarily focuses its operations in the M …
  • Kimura Unity Co., Ltd. (9368):企業概要、財務及び戦略的SWOT分析
    Summary KIMURA UNITY CO., LTD. (KIMURA) is a business and consumer service provider. The company offers logistics services, car services, information services, and staffing services. Its logistics services include outsourcing and contract work, logistics system development, and distribution equipmen …
  • TeleTracking Technologies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TeleTracking Technologies, Inc. …
  • Cosan S.A. Industria e Comercio (CSAN3):企業のM&A・提携動向(石油・ガス分野)
    Summary Cosan S.A. Industria e Comercio (Cosan) is an integrated bioenergy company. It produces, transports and distributes renewable energy sources. It processes sugarcane, transports and sells sugars, distributes fuel in domestic and international markets; and distributes natural gas and manufactu …
  • Rollins, Inc. (ROL):企業の財務及び戦略的SWOT分析
    Summary Rollins, Inc. (Rollins) is a consumer and commercial service provider that offers essential pest control services and protection against termite damage, rodents and insects. The company offers its services through its international franchises. It also offers customized services to its client …
  • American Tower Corporation:企業の戦略・SWOT・財務分析
    SummaryAmerican Tower Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • SeraCare Life Sciences, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SeraCare Life Sciences, Inc. Me …
  • Technofan SA:企業の戦略・SWOT・財務分析
    SummaryTechnofan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆